Stadapham Nifedipin T20 retard

Nifedipin T20 retard is a pharmaceutical product containing Nifedipine, a calcium channel blocker used primarily for the treatment of hypertension and angina. This specific version is manufactured by STADA-VN Joint Venture Co., Ltd. (Stadapharm), which represents a significant partnership in the Southeast Asian pharmaceutical market. The product is frequently distributed in Cambodia, as evidenced by the Khmer script and Preah Ket Mealea Hospital labeling visible on the prescription bag.

The brand is under the ultimate ownership of STADA Arzneimittel AG, a leading global manufacturer of high-quality generic drugs and consumer healthcare products based in Germany. The manufacturing for this specific product is localized in Vietnam to serve the regional market, utilizing STADA's international standards for pharmaceutical production. The ownership structure reflects a common model where a major European pharmaceutical entity establishes joint ventures or subsidiaries to localize production and distribution in emerging markets.